Boston Financial Mangement LLC Pfizer Inc Transaction History

Boston Financial Mangement LLC

$3.23 Billion
Q3 2024

A detailed history of Boston Financial Mangement LLC transactions in Pfizer Inc stock. As of the latest transaction made, Boston Financial Mangement LLC holds 791,150 shares of PFE stock, worth $21.2 Million. This represents 0.71% of its overall portfolio holdings.

Number of Shares

791,150

Previous 1,312,318 39.71%

Holding current value

$21.2 Million

Previous $36.7 Million 37.65%

% of portfolio

0.71%

Previous 1.18%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$27.7 - $31.39 $14.4 Million - $16.4 Million	-521,168 Reduced 39.71%	791,150 $22.9 Million
Q2 2024 Jul 29, 2024	SELL	$25.26 - $29.6 $109,325 - $128,108	-4,328 Reduced 0.33%	1,312,318 $36.7 Million
Q1 2024 May 10, 2024	SELL	$25.89 - $29.73 $236,634 - $271,732	-9,140 Reduced 0.69%	1,316,646 $36.5 Million
Q4 2023 Feb 12, 2024	SELL	$26.13 - $33.94 $301,357 - $391,430	-11,533 Reduced 0.86%	1,325,786 $38.2 Million
Q3 2023 Nov 09, 2023	SELL	$32.09 - $37.51 $24,324 - $28,432	-758 Reduced 0.06%	1,337,319 $44.4 Million
Q2 2023 Aug 07, 2023	SELL	$36.12 - $41.79 $325,477 - $376,569	-9,011 Reduced 0.67%	1,338,077 $49.1 Million
Q1 2023 May 12, 2023	BUY	$39.39 - $51.28 $200,967 - $261,630	5,102 Added 0.38%	1,347,088 $55 Million
Q4 2022 Jan 27, 2023	BUY	$41.75 - $54.5 $54,525 - $71,177	1,306 Added 0.1%	1,341,986 $0
Q3 2022 Nov 09, 2022	SELL	$43.76 - $53.42 $34,045 - $41,560	-778 Reduced 0.06%	1,340,680 $58.7 Million
Q2 2022 Aug 08, 2022	BUY	$46.53 - $55.17 $240,327 - $284,953	5,165 Added 0.39%	1,341,458 $70.3 Million
Q1 2022 May 13, 2022	BUY	$45.75 - $56.69 $155,092 - $192,179	3,390 Added 0.25%	1,336,293 $69.2 Million
Q4 2021 Feb 11, 2022	SELL	$41.32 - $61.25 $236,557 - $350,656	-5,725 Reduced 0.43%	1,332,903 $78.7 Million
Q3 2021 Nov 12, 2021	BUY	$39.25 - $50.42 $255,792 - $328,587	6,517 Added 0.49%	1,338,628 $57.6 Million
Q2 2021 Aug 03, 2021	SELL	$35.91 - $40.68 $61,442 - $69,603	-1,711 Reduced 0.13%	1,332,111 $52.2 Million
Q1 2021 May 07, 2021	SELL	$33.49 - $37.77 $1.41 Million - $1.59 Million	-42,012 Reduced 3.05%	1,333,822 $48.3 Million
Q4 2020 Feb 10, 2021	SELL	$33.47 - $42.56 $3.39 Million - $4.31 Million	-101,180 Reduced 6.85%	1,375,834 $50.6 Million
Q3 2020 Nov 12, 2020	SELL	$31.75 - $37.25 $27,908 - $32,742	-879 Reduced 0.06%	1,477,014 $54.2 Million
Q2 2020 Aug 10, 2020	SELL	$30.12 - $36.54 $159,425 - $193,406	-5,293 Reduced 0.36%	1,477,893 $48.3 Million
Q1 2020 May 05, 2020	SELL	$27.03 - $38.62 $303,546 - $433,702	-11,230 Reduced 0.75%	1,483,186 $48.4 Million
Q4 2019 Feb 05, 2020	SELL	$32.92 - $37.36 $749,522 - $850,612	-22,768 Reduced 1.5%	1,494,416 $58.6 Million
Q3 2019 Nov 08, 2019	SELL	$32.49 - $42.13 $118,815 - $154,069	-3,657 Reduced 0.24%	1,517,184 $54.5 Million
Q2 2019 Jul 24, 2019	SELL	$36.98 - $41.52 $732,130 - $822,012	-19,798 Reduced 1.29%	1,520,841 $65.9 Million
Q1 2019 Apr 25, 2019	SELL	$37.5 - $41.2 $260,662 - $286,381	-6,951 Reduced 0.45%	1,540,639 $65.4 Million
Q4 2018 Jan 31, 2019	SELL	$38.47 - $43.86 $1.06 Million - $1.21 Million	-27,554 Reduced 1.75%	1,547,590 $67.6 Million
Q3 2018 Nov 02, 2018	BUY	$34.47 - $41.81 $148,634 - $180,284	4,312 Added 0.27%	1,575,144 $69.4 Million
Q2 2018 Aug 03, 2018	BUY	$32.98 - $35.16 $88,716 - $94,580	2,690 Added 0.17%	1,570,832 $57 Million
Q1 2018 Apr 25, 2018	SELL	$31.91 - $37.02 $385,504 - $447,238	-12,081 Reduced 0.76%	1,568,142 $55.7 Million
Q4 2017 Feb 05, 2018	SELL	$33.26 - $35.29 $241,434 - $256,170	-7,259 Reduced 0.46%	1,580,223 $57.2 Million
Q3 2017 Oct 30, 2017	BUY	$31.0 - $34.15 $49.2 Million - $54.2 Million	1,587,482	1,587,482 $56.7 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Financial Mangement LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boston Financial Mangement LLC with notifications on news.

Account

Boston Financial Mangement LLC Pfizer Inc Transaction History